| Literature DB >> 222019 |
R M Condie, B L Hall, R J Howard, D Fryd, R L Simmons, J S Najarian.
Abstract
This study demonstrates that large doses of human IgG can, if prepared by appropriate methods, be safely given intravenously. Antibody titers to CMV can be significantly elevated by administration of MIVIgG. While this is not a controlled trial, IgG therapy appears to be beneficial in renal transplant patients presenting with life-threatening infections.Entities:
Mesh：
Substances：
Year: 1979 PMID： 222019
Source DB: PubMed Journal: Transplant Proc ISSN： 0041-1345 Impact factor: 1.066